Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55,632,823
-
Total 13F shares
-
33,689,325
-
Share change
-
+3,649,744
-
Total reported value
-
$132,427,477
-
Put/Call ratio
-
12%
-
Price per share
-
$3.93
-
Number of holders
-
121
-
Value change
-
+$14,168,768
-
Number of buys
-
47
-
Number of sells
-
52
Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q4 2025
As of 31 Dec 2025,
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,689,325 shares.
The largest 10 holders included
BlackRock, Inc., EcoR1 Capital, LLC, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Vestal Point Capital, LP, Opaleye Management Inc., Erste Asset Management GmbH, GEODE CAPITAL MANAGEMENT, LLC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
121
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.